 |
 |

Clinically Undetected Motor Neuron Disease in Pathologically Proven Frontotemporal Lobar Degeneration With Motor Neuron Disease
Keith A. Josephs, MST, MD;
Joseph E. Parisi, MD;
David S. Knopman, MD;
Bradley F. Boeve, MD;
Ronald C. Petersen, MD, PhD;
Dennis W. Dickson, MD
Arch Neurol. 2006;63:506-512.
Background Frontotemporal lobar degeneration with motor neuron disease (FTLD-MND) is a pathological entity characterized by motor neuron degeneration and frontotemporal lobar degeneration. The ability to detect the clinical signs of dementia and motor neuron disease in pathologically confirmed FTLD-MND has not been assessed.
Objectives To determine if all cases of pathologically confirmed FTLD-MND have clinical evidence of frontotemporal dementia and motor neuron disease, and to determine the possible reasons for misdiagnosis.
Method Review of historical records and semiquantitative analysis of the motor and extramotor pathological findings of all cases of pathologically confirmed FTLD-MND.
Results From a total of 17 cases of pathologically confirmed FTLD-MND, all had clinical evidence of frontotemporal dementia, while only 10 (59%) had clinical evidence of motor neuron disease. Semiquantitative analysis of motor and extramotor pathological findings revealed a spectrum of pathological changes underlying FTLD-MND. Hippocampal sclerosis, predominantly of the subiculum, was a significantly more frequent occurrence in the cases without clinical evidence of motor neuron disease (P<.01). In addition, neuronal loss, gliosis, and corticospinal tract degeneration were less severe in the other 3 cases without clinical evidence of motor neuron disease.
Conclusions Clinical diagnostic sensitivity for the elements of FTLD-MND is modest and may be affected by the fact that FTLD-MND represents a spectrum of pathological findings, rather than a single homogeneous entity. Detection of signs of clinical motor neuron disease is also difficult when motor neuron degeneration is mild and in patients with hippocampal sclerosis.
Author Affiliations: Departments of Neurology (Drs Josephs, Knopman, Boeve, and Petersen) and Laboratory Medicine and Pathology (Dr Parisi), Mayo Clinic, Rochester, Minn; Department of Pathology and Neuroscience (Dr Dickson), Mayo Clinic, Jacksonville, Fla.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
Frontotemporal Lobar Degeneration With Motor Neuron Disease: A Clinical and Pathological Spectrum
Christopher M. Clark and Mark S. Forman
Arch Neurol. 2006;63(4):489-490.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Rapidly Progressive Neurodegenerative Dementias
Josephs et al.
Arch Neurol 2009;66:201-207.
ABSTRACT
| FULL TEXT
Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register
Kurian et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:84-87.
ABSTRACT
| FULL TEXT
Distinct genetic forms of frontotemporal dementia
Seelaar et al.
Neurology 2008;71:1220-1226.
ABSTRACT
| FULL TEXT
FRONTOTEMPORAL LOBAR DEGENERATION WITH UPPER MOTOR NEURON DISEASE/ PRIMARY LATERAL SCLEROSIS
Josephs and Dickson
Neurology 2007;69:1800-1801.
FULL TEXT
TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations
Seelaar et al.
Brain 2007;130:1375-1385.
ABSTRACT
| FULL TEXT
Rates of cerebral atrophy differ in different degenerative pathologies
Whitwell et al.
Brain 2007;130:1148-1158.
ABSTRACT
| FULL TEXT
Voxel-Based Morphometry in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With and Without Progranulin Mutations
Whitwell et al.
Arch Neurol 2007;64:371-376.
ABSTRACT
| FULL TEXT
A 34-year-old man with progressive behavioral and language disturbance
Miller et al.
Neurology 2007;68:68-74.
FULL TEXT
Frontotemporal Lobar Degeneration Without Lobar Atrophy
Josephs et al.
Arch Neurol 2006;63:1632-1638.
ABSTRACT
| FULL TEXT
Frontotemporal lobar degeneration with motor neuron disease: a clinical and pathological spectrum.
Clark and Forman
Arch Neurol 2006;63:489-490.
FULL TEXT
|